Gary Lee
Chief Tech/Sci/R&D Officer chez LYELL IMMUNOPHARMA, INC.
Fortune : 28 321 $ au 31/03/2024
Profil
Gary Lee is currently the Chief Scientific Officer at Lyell Immunopharma, Inc. He was previously the Vice President-Cell Therapy at Sangamo Therapeutics, Inc. from 2005 to 2018 and the Chief Scientific Officer at Senti Sub I, Inc. from 2018 to 2022.
He received his undergraduate degree from the California Institute of Technology and his doctorate from the University of California, Berkeley.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LYELL IMMUNOPHARMA, INC.
0,00% | 31/03/2024 | 12 700 ( 0,00% ) | 28 321 $ | 31/03/2024 |
Postes actifs de Gary Lee
| Sociétés | Poste | Début |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 31/01/2022 |
Anciens postes connus de Gary Lee
| Sociétés | Poste | Fin |
|---|---|---|
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/01/2022 |
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2018 |
Formation de Gary Lee
| California Institute of Technology | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| LYELL IMMUNOPHARMA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
